Osteopathy In Mild Adrenal Cushing'S Syndrome And Cushing Disease

Stefano Frara,Agnese Allora,Luigi di Filippo,Anna Maria Formenti,Paola Loli, Elisabetta Polizzi,Daniele Tradati,Fabio Massimo Ulivieri,Andrea Giustina

BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM（2021）

引用 15|浏览3

暂无评分

摘要

Pathophysiology and effects of endogenous glucocorticoid (GC) excess on skeletal endpoints as well as awareness and management of bone fragility are reviewed. Cushing's syndrome (CS) increase the risk of fracture affecting prevalently bone quality. Bone antiresorptive agents (SERMs, bisphosphonates and denosumab) as well as teriparatide increase bone mineral density and in some instances reduce fracture risk. Awareness and management of bone health in CS can be improved.(c) 2021 Elsevier Ltd. All rights reserved.

查看译文

关键词

bone mineral density, fractures, glucocorticoids, bone quality, cushing disease, adrenal incidentaloma

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要